We are live on ! Find out more
CCM

Compass Capital Management Portfolio holdings

AUM $1.66B
1-Year Est. Return 7.83%
This Fund
S&P 500
This Quarter Est. Return
-7.23%
1 Year Est. Return
+7.83%
3 Year Est. Return
+47.1%
5 Year Est. Return
+55.91%
10 Year Est. Return
+237.22%
AUM
$1.4B
AUM Growth
-$90.7M
Cap. Flow
+$22.9M
Cap. Flow %
1.63%
Top 10 Hldgs %
42.01%
Holding
36
New
1
Increased
19
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
APH icon
Amphenol
APH
+$54.2M
2
ECL icon
Ecolab
ECL
+$8.69M
3
SHW icon
Sherwin-Williams
SHW
+$6.28M
4
EXPD icon
Expeditors International
EXPD
+$4.91M
5
DIS icon
Walt Disney
DIS
+$3.73M

Sector Composition

Rank Sector Weight
1 Technology 32.18%
2 Healthcare 20.63%
3 Industrials 15.13%
4 Financials 8.45%
5 Consumer Staples 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.35T
$64.6M 4.6%
209,449
-345
-0.2% -$104K
FAST icon
2
Fastenal
FAST
$53.5B
$59.6M 4.25%
2,006,602
+42,122
+2% +$1.18M
TMO icon
3
Thermo Fisher Scientific
TMO
$214B
$59.1M 4.21%
100,070
+1,107
+1% +$636K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.08T
$58.9M 4.2%
423,360
+4,020
+1% +$546K
DHR icon
5
Danaher
DHR
$138B
$58.7M 4.19%
225,771
+9,443
+4% +$2.36M
SYK icon
6
Stryker
SYK
$133B
$58.5M 4.17%
218,758
+3,122
+1% +$808K
V icon
7
Visa
V
$684B
$58M 4.14%
261,613
-771
-0.3% -$167K
CHD icon
8
Church & Dwight Co
CHD
$23.1B
$57.5M 4.1%
579,028
-30,067
-5% -$3M
JNJ icon
9
Johnson & Johnson
JNJ
$617B
$57.4M 4.09%
323,607
+4,464
+1% +$760K
CTSH icon
10
Cognizant
CTSH
$24.3B
$56.9M 4.06%
634,260
-53,514
-8% -$4.7M
ICE icon
11
Intercontinental Exchange
ICE
$87.7B
$56.2M 4.01%
425,316
+81
+0% +$10.5K
WMT icon
12
Walmart Inc
WMT
$884B
$56.1M 4%
1,131,042
+27,606
+3% +$1.3M
CHKP icon
13
Check Point Software Technologies
CHKP
$13.1B
$56M 3.99%
405,024
-43,193
-10% -$5.64M
CVS icon
14
CVS Health
CVS
$134B
$55.7M 3.97%
550,362
-69,757
-11% -$7.33M
ROP icon
15
Roper Technologies
ROP
$38.5B
$55.4M 3.95%
117,259
+3,281
+3% +$1.48M
ACN icon
16
Accenture
ACN
$99.9B
$55.1M 3.93%
163,435
+4,718
+3% +$1.59M
QCOM icon
17
Qualcomm
QCOM
$159B
$54M 3.85%
353,048
+6,495
+2% +$1.09M
FISV
18
Fiserv Inc
FISV
$28.8B
$53.3M 3.8%
525,939
+9,118
+2% +$923K
APH icon
19
Amphenol
APH
$197B
$52.8M 3.76%
+1,400,156
New +$54.2M
SHW icon
20
Sherwin-Williams
SHW
$83.7B
$52.5M 3.74%
210,137
+22,743
+12% +$6.28M
FDX icon
21
FedEx
FDX
$73B
$52.3M 3.73%
226,036
+12,118
+6% +$2.85M
DIS icon
22
Walt Disney
DIS
$167B
$51.2M 3.65%
373,045
+25,802
+7% +$3.73M
EXPD icon
23
Expeditors International
EXPD
$21.8B
$50.7M 3.62%
491,918
+44,568
+10% +$4.91M
ECL icon
24
Ecolab
ECL
$78.6B
$49.8M 3.55%
282,146
+46,259
+20% +$8.69M
ITW icon
25
Illinois Tool Works
ITW
$81.6B
$49.6M 3.54%
236,742
+5,146
+2% +$1.15M

Similar funds

Compass Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Compass Capital Management held 36 positions worth $1.4B, down 6.1% from $1.49B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Compass Capital Management's Q1 2022 filing shows 1 new, 19 increased, 10 reduced and 3 closed positions. Its largest new stake was Amphenol: 1,400,156 shares worth $52.8M. The largest sale was Medtronic, an estimated $49.7M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Compass Capital Management's largest Q1 2022 buy was Amphenol: 1,400,156 shares worth $52.8M.
  • Compass Capital Management added most to Ecolab in Q1 2022, an estimated $8.69M increase.
  • Compass Capital Management's biggest Q1 2022 reduction was CVS Health, cutting an estimated $7.33M.
  • Compass Capital Management fully exited Medtronic in Q1 2022, selling an estimated $49.7M.
  • Compass Capital Management's ten largest holdings make up 42% of its $1.4B portfolio in Q1 2022.
  • Compass Capital Management opened 1 new position and closed 3 in Q1 2022.
  • Compass Capital Management's portfolio value fell 6.1% quarter-over-quarter to $1.4B.

Based on Compass Capital Management's 13F filing for Q1 2022, filed 6 May 2022.